Chemoinformaics analysis of allo-Aromadendrene epoxide
| Molecular Weight | 252.398 | nRot | 8 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 6 |
| Exact Molecular Weight | 252.209 | nRing | 0 |
| Solubility: LogS | -6.9 | nHRing | 0 |
| Solubility: LogP | 7.647 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 46.9942 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.424 |
| Synth | 2.182 |
| Natural Product Likeliness | 0.444 |
| NR-PPAR-gamma | 0.042 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.19 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.549 |
| MDCK | 0.00000793 |
| BBB | 0.259 |
| PPB | 0.983459 |
| VDSS | 2.619 |
| FU | 0.00842594 |
| CYP1A2-inh | 0.633 |
| CYP1A2-sub | 0.539 |
| CYP2c19-inh | 0.604 |
| CYP2c19-sub | 0.159 |
| CYP2c9-inh | 0.391 |
| CYP2c9-sub | 0.943 |
| CYP2d6-inh | 0.153 |
| CYP2d6-sub | 0.095 |
| CYP3a4-inh | 0.453 |
| CYP3a4-sub | 0.24 |
| CL | 5.138 |
| T12 | 0.06 |
| hERG | 0.151 |
| Ames | 0.01 |
| ROA | 0.112 |
| SkinSen | 0.926 |
| Carcinogencity | 0.053 |
| EI | 0.988 |
| Respiratory | 0.229 |
| NR-Aromatase | 0.026 |
| Antiviral | Yes |
| Prediction | 0.764161 |